Additional inhibitor can help anti-VEGF therapy overcome resistance in deadly brain cancer
A study published in Nature Communications finds that adding an inhibitor to cancer therapies could cut off a tumor’s access to blood vessels, helping therapies overcome resistance in gioblastomas.
FULL STORY AT Penn Medicine News →